DP13 - A Phase II Study in Patients With Primary Aldosteronism

Condition:   Primary Aldosteronism Intervention:   Drug: DP13 Sponsor:   Damian Pharma AG Not yet recruiting

Source: ClinicalTrials.gov - July 3, 2019 Category: Research Source Type: clinical trials